FluoRok Secures $30 Million for Safer Fluorochemical Production
Oxford spin-out FluoRok raised $30 million in Series A funding to scale its hydrogen fluoride-free process for making critical fluorochemicals, targeting pharmaceuticals and battery manufacturing.

FluoRok has secured $30 million in Series A funding led by Orano Venture Fund and Supernova Invest to accelerate industrial scale-up. The round, which exceeded its original target, brings the company's total equity funding to approximately $44 million. It also included about $1.3 million in Innovate UK grant funding, with CPI Enterprises joining as a scale-up partner.
Technology Solving Industry Safety and Supply Challenges
FluoRok's patented process eliminates the use of hydrogen fluoride (HF) in fluorochemical production. This bypasses a conventional 250-year-old method that relies on the highly hazardous HF and on high-purity fluorspar, a mineral predominantly sourced from China. The company aims to produce battery and pharmaceutical chemicals without this toxic material.
The startup targets the pharmaceuticals, agrochemicals, and lithium-ion battery manufacturing sectors. It has already completed pilot qualifications and has products validated by more than ten partners across eight countries and three continents. China currently produces 85-90% of lithium hexafluorophosphate (LiPF6), a key battery chemical, using the hazardous HF-based process.
Strategic Expansion Plans
The new capital will fund FluoRok's transition from startup to industrial scale. This includes building demonstrator facilities for reagents and battery electrolyte salts. The funding will also support team expansion and deeper commercial partnerships.
FluoRok plans to scale its platform for next-generation battery products like LiFSI and FEC. It is also developing a waste-to-value stream targeting over 25,000 tonnes of fluorinated polymer waste incinerated annually in Europe. The company has previously secured over $14 million in funding rounds and received more than $13 million in UK and European public grants.
Foundational Support and Market Context
FluoRok is an Oxford spinout founded in 2022 by Véronique Gouverneur and Gabriele Pupo. Oxford Science Enterprises provided an initial £3 million investment in July 2023, followed by a £7.7 million round led by BGF and Green Generation Fund in September 2024.
The move comes as the EU's ReSourceEU plan commits up to €3 billion in 2026 to critical raw materials. FluoRok’s European Innovation Council project aims to establish it as the first EU-based LiPF6 producer, a market currently dominated by firms like Do-Fluoride, Tinci, Capchem, and Foosung. Notably, Orbia’s Koura operation is building a 10,000-tonne-per-year LiPF6 plant in Louisiana.
Dr. Gabriele Pupo said: "We are thrilled to welcome new investors on our journey to fundamentally change how the world makes fluorochemicals, with safer chemistry and better economics." The company will now focus on building demonstrator facilities for reagents and battery electrolyte salts to complete its transition to industrial scale.





